Highlights and Quick Summary
- EPS Growth (diluted) for the quarter ending June 30, 2023 was -6.93% (a -46.86% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (diluted) decreased by -291.97%
- Annual EPS Growth (diluted) for 2022 was -10.24% (a -135.24% decrease from previous year)
- Annual EPS Growth (diluted) for 2021 was 29.06% (a -102.52% decrease from previous year)
- Annual EPS Growth (diluted) for 2020 was -1151.52% (a 475.76% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (diluted) of Dyne Therapeutics, Inc.
Most recent EPS Growth (diluted)of DYN including historical data for past 10 years.Interactive Chart of EPS Growth (diluted) of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -6.93% | -13.04% | – | – | – |
| 2022 | 26.0% | 3.61% | -74.14% | -38.0% | -10.24% |
| 2021 | – | -56.25% | 58.71% | -346.15% | 29.06% |
| 2020 | – | – | 36.0% | -142.17% | -1151.52% |
| 2019 | – | – | – | 77.59% | -200.0% |
| 2018 | – | – | – | – | 66.67% |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology